Fresenius Kabi Oncology’s director resigns

03 Feb 2012 Evaluate

Fresenius Kabi Oncology has informed that the board of directors of the company at its meeting held on February 02, 2012, has taken on record the resignation of Anand C. Burman as the non-executive director of the company with effect from February 02, 2012.

The above information is part of company’s filing submitted to the BSE. 

Peers
Company Name CMP
Sun Pharma Inds. 1530.00
Dr. Reddys Lab 5808.80
Cipla 1404.90
Zydus Lifesciences 1036.95
Lupin 1652.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.